Asthma Severity May Be Identified Via Total Airway Count on Computed Tomography
Thickened airway walls, which correlate with airway obstruction and/or occlusion, are greatly increased in patients with severe asthma.
News
LATEST NEWS
Long-Term Benralizumab Use Is Efficacious in Severe, Eosinophilic Asthma
Long-term benralizumab use is efficacious for patients with severe, uncontrolled asthma with elevated eosinophil counts.
Tuberculosis Pleural Effusion Diagnosis: Accuracy of Genotype Line Probe Assay
Despite having a good specificity for tuberculous pleural effusion diagnosis, genotype MTBDRplus line probe assay could not be included in most diagnostic algorithms as a result of its low sensitivity.
California May Start Producing Its Own Medicines
A proposal for California to contract generic drug companies to make medications would make the state the first in the country to produce its own medications.
COPD Subtype Classification: Analysis of the COPDGene Study
Continuous evaluation of participants in the COPDGene study will provide useful insights that will enable better identification of disease subtypes.
New Jersey Lawmakers Pass Bill to Ban Flavored Vaping Products
A bill that would ban the sale of flavored vaping products in New Jersey will take effect 90 days after being signed by the governor.
Changes in FDA Drug Approval and Regulation Processes
FDA drug review times have decreased, but the time from clinical testing to approval did not change.
Burnout in Medical Students Tied to Perceived Stress, Phone Behavior
The majority of osteopathic medical students report low sense of personal accomplishment.
UPCOMING MEETINGS
FEBRUARY 22-25
American Academy of Allergy, Asthma and Immunology (AAAAI) 2019 Annual Meeting
San Francisco, CA
February 27-28
5th International Conference on Respiratory and Pulmonary Medicine
Paris, France
April 10-13
ELCC 2019: European Lung Cancer Conference
Geneva, Switzerland
DRUG NEWS FROM MPR
FDA: Cases of Respiratory Depression With Gabapentinoids Reported
New Cheek Swab Helps Rule Out Genetic Form of COPD
FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation
Mepolizumab Approved for Younger Patients With Severe Eosinophilic Asthma
Fixed-Dose, Triple-Combination Therapy Effective in COPD Trial
Nangibotide Gets Fast Track Status for Treatment of Septic Shock
Rovalpituzumab Tesirine Program Ends After Poor Results in Lung Cancer Trial
Entrectinib Receives FDA Approval for Non-Small Cell Lung Cancer
Molgramostim Misses Primary End Point in Alveolar Pulmonary Proteinosis Trial
CDC Announces Number of Expired Flu Vaccines Administered Last Season
Sildenafil for Oral Suspension Available to Treat Pulmonary Arterial Hypertension
Glass Fragment Prompts Recall of Immunosuppressive Agent
Inhaled Molgramostim Granted Fast Track Status for Autoimmune Pulmonary Alveolar Proteinosis
Aclidinium Bromide and Formoterol Fumarate Approved for COPD Maintenance Treatment
Recombinant Human Pentraxin-2 Gets Breakthrough Tx Designation for Idiopathic Pulmonary Fibrosis
Want to read more?
Please login or register first to view this content.
Next post in News
